In this issue of the journal, Dimitriu-Leen et al. addressed a question of whether an early late imaging (e.g., 1, 2, or 3 hours after tracer injection) can be used as an alternative to 4 hour 123 I-MIBG imaging in terms of heart-tomediastinum uptake ratio (HMR) and washout rate (WR). They found that, by applying the linear regression model, HMR and WR obtained at 3 hours after injection can accurately estimate those at 4 hours. Additionally, the parameters estimated at 2 hours showed a close correlation to those at 4 hours. This study shows that a shorter imaging protocol is feasible without loss of clinical significance as compared to 4 hour imaging, which is certainly more convenient for the patients. More importantly, collected 123 I-MIBG imaging data from different acquisition protocols can directly be compared and exchangeable. Because we now have tools for standardization of data derived from different camera systems, the results of this study would further facilitate the use of 123 I-MIBG imaging as a reliable aid for risk stratification of HF patients.
Additionally, the parameters estimated at 2 hours showed a close correlation to those at 4 hours. Therefore, they concluded that the accurate estimation of the actual HMR and WR at 4
hours is possible using acquisition data at 2 and 3 hours.
Furthermore, they also demonstrated in this (5) and their prior study (7) that HMR is rather stable between 2 and 4 hours, whereas WR increases as the scan time is delayed. For this reason, they recommend to use a 3 hour rather than 2 hour
